GLP-1 Receptor Agonists and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
June 2025
New to Minoxidil? There is a guide in the encyclopedia. Read the guide → 
Studysummary This review highlights concerns about dermatological side effects linked to rapid weight loss from glucagon-like peptide-1 receptor agonists used for type 2 diabetes and obesity treatment, such as skin laxity, decreased collagen, and hair loss, emphasizing the importance of managing these while retaining metabolic benefits. Our plain-language summary of this paper — not a Tressless recommendation.
GLP-1 receptor agonists (GLP-1 RAs), used for type 2 diabetes and obesity, can cause dermatological side effects like "Ozempic face," skin sagging, dehydration, and hair loss due to rapid weight loss. These effects stem from nutrient deficiencies, mitochondrial dysfunction, and hormonal changes rather than direct drug action. About 12% of patients experience hair loss, often reversible with treatments like nutritional supplements and minoxidil. Mitigation strategies include maintaining hydration, balanced nutrition, and using skincare products such as ceramide-rich moisturizers and retinoids. Healthcare providers should consider co-management with dermatology specialists to address these issues.
